These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15352901)

  • 1. Review article: the management of mild to severe acute ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the long-term management of ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():97-101. PubMed ID: 15352903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():15-21. PubMed ID: 18307645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment.
    Benazzato L; D'Incà R; Grigoletto F; Perissinotto E; Medici V; Angriman I; Sturniolo GC
    Dig Liver Dis; 2004 Jul; 36(7):461-6. PubMed ID: 15285525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the management of steroid dependency in ulcerative colitis.
    Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S
    Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balsalazide disodium for the treatment of ulcerative colitis.
    Patil SA; Moss AC
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):177-84. PubMed ID: 19072352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Take your medicine": nonadherence issues in patients with ulcerative colitis.
    Turnbough L; Wilson L
    Gastroenterol Nurs; 2007; 30(3):212-7; quiz 218-9. PubMed ID: 17568260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: systemic and topical steroids in inflammatory bowel disease.
    Schölmerich J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
    Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():37-40. PubMed ID: 16961743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ulcerative colitis.
    Ludwig D; Stange EF
    Hepatogastroenterology; 2000; 47(31):83-9. PubMed ID: 10690588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.